Boehringer Ingelheim Pharmaceuticals, Inc.
1
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-07-08 to 2026-07-08
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-07-08 | FDA Drug | FDA Recall: Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 | Boehringer Ingelheim Pharmaceuticals, Inc. | Class II | N/A |